Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
US-headquartered pharmaceutical multinational, West Pharmaceutical Services has created 330 new jobs as a result of opening of a major manufacturing expansion at its Damastown site in Dublin. Most of the roles have already been filled.
The new facility was officially launched in March 2026 and supports high volume production of drug delivery systems used in treatments for diabetes and obesity.
Public authorities were involved in welcoming the investment. IDA Ireland and the Minister for Public Expenditure, Infrastructure, Public Service Reform and Digitalisationwelcomed the opening of the new facility, describing it as beneficial for both the local community and the national life sciences sector.
The company employs more than 10,000 people in 50 global locations, including 1,400 in Ireland across sites in Dublin and Waterford. West said the investment strengthens its global manufacturing capacity and underlines Ireland’s role as a hub for advanced pharmaceutical and medtech production.
Eurofound (2026), West Pharmaceuticals, Business expansion in Ireland, factsheet number 204572, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/204572.